lobbying_filings_raw: f8fc6cf2-23fd-4465-9b00-6d451bfa96f8
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| f8fc6cf2-23fd-4465-9b00-6d451bfa96f8 | Q1 | 12868 | DUTKO WORLDWIDE, LLC | 118111 | ABBOTT LABORATORIES | 2009 | first_quarter | 2009-04-08T12:32:07-04:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/f8fc6cf2-23fd-4465-9b00-6d451bfa96f8/", "filing_uuid": "f8fc6cf2-23fd-4465-9b00-6d451bfa96f8", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2009, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f8fc6cf2-23fd-4465-9b00-6d451bfa96f8/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Mark Irion, Chief Executive Officer", "dt_posted": "2009-04-08T12:32:07-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "412 FIRST STREET SE", "registrant_address_2": "SUITE 100", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20003", "registrant": {"id": 12868, "url": "https://lda.senate.gov/api/v1/registrants/12868/", "house_registrant_id": 32229, "name": "DUTKO WORLDWIDE, LLC", "description": "Government relations firm", "address_1": "80 M STREET SE", "address_2": "SUITE 130", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20003", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "CHRIS ANDRESEN", "contact_telephone": "+1 202-851-3618", "dt_updated": "2026-01-26T17:43:32.412214-05:00"}, "client": {"id": 118111, "url": "https://lda.senate.gov/api/v1/clients/118111/", "client_id": 4950, "name": "ABBOTT LABORATORIES", "general_description": null, "client_government_entity": false, "client_self_select": false, "state": "FL", "state_display": "Florida", "country": "US", "country_display": "United States of America", "ppb_state": "FL", "ppb_state_display": "Florida", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-03"}, "lobbying_activities": [{"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4072, "prefix": null, "prefix_display": null, "first_name": "DARREN", "nickname": null, "middle_name": null, "last_name": "WILLCOX", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4072, "prefix": null, "prefix_display": null, "first_name": "DARREN", "nickname": null, "middle_name": null, "last_name": "WILLCOX", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4072, "prefix": null, "prefix_display": null, "first_name": "DARREN", "nickname": null, "middle_name": null, "last_name": "WILLCOX", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 32229 | FL | FL | US | US | 0 | 0 | 30000.0 |